chartexchange

Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA® (vonoprazan) Tablets Exclusively at BlinkRx

GlobeNewswire Inc. | Nov 3, 2026 8:00 AM EST

A Media Snippet accompanying this announcement is available by clicking on this link.

Read original article